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Abstract 
Background: The characteristics of intracerebral haemorrhage (ICH) may vary by 
ICH location because of differences in the distribution of underlying cerebral small 
vessel diseases. Therefore, we investigated the incidence, characteristics and outcome 
of lobar and non-lobar ICH. 
Methods: In a population-based, prospective inception cohort study of ICH, we used 
multiple overlapping sources of case ascertainment and follow-up to identify and 
validate 166 ICH diagnoses in 2010-2011 in an adult population of 695,335. 
Results: The overall incidence of lobar ICH was similar to non-lobar ICH (9.8 [95% 
confidence interval (CI) 7.7-12.4] versus 8.6 [95%CI 6.7-11.1] per 100,000 adults per 
year). At baseline, adults with lobar ICH were more likely to have preceding dementia 
(21% vs. 5%, p=0.01), lower Glasgow Coma Scale scores (median 13 vs. 14, p=0.03), 
larger ICHs (median 38ml vs. 11ml, p<0.001), subarachnoid extension (57% vs. 5%, 
p<0.001), and subdural extension (15% vs. 3%, p=0.02) than those with non-lobar 
ICH. One year case fatality was lower after lobar ICH than after non-lobar ICH 
(adjusted OR for death at one year: lobar vs. non-lobar ICH 0.21, 95% CI 0.07 to 
0.63; p=0.006, after adjustment for known predictors of outcome).  There were four 
recurrent ICHs, which occurred exclusively in survivors of lobar ICH (annual risk of 
recurrent ICH after lobar ICH 11.8%, 95% CI 4.6% to 28.5% vs. 0% after non-lobar 
ICH; log-rank p=0.04). 
Conclusion: The baseline characteristics and outcome of lobar ICH differ from other 
locations. 
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Introduction 
Spontaneous (non-traumatic) intracerebral haemorrhage (ICH) accounts for ~10% of 
all strokes in Western populations.[1] Roughly four-fifths of ICHs with no apparent 
cause (so-called ‘primary’ ICH[2]) are usually attributed to small vessel 
vasculopathies such as arteriolosclerosis or cerebral amyloid angiopathy (CAA). This 
attribution is usually made on the basis of risk factors, clinical and radiographic 
features,[3] such as those described by the modified Boston criteria for ‘CAA-related’ 
ICH.[4,5] 
The incidence of lobar primary ICH appears to be increasing,[1,6] possibly due to 
antithrombotic drugs.[7] One year case fatality after primary ICH is ~55%,[1] but it is 
higher after infratentorial ICH.[8,9] However, most ICHs are supratentorial and the 
influence of supratentorial ICH location on outcome remains unclear. Lobar ICH may 
have a better prognosis in comparison to ICH in other locations,[10-13] or it may 
not,[14-20] and the risk of recurrence may be higher after lobar ICH.[21] 
Determining whether risk factors and outcome differ according to ICH location has 
been further complicated by studies’ varied definitions of ICH location.  Of 41 
observational studies comparing lobar and non-lobar ICH, 20 did not define lobar 
location,[18,22-40] and 21 used different definitions of lobar location (including ICH 
which was cortical and/or subcortical,[41-46] cerebellar,[47] predominantly cortical 
and/or  involving underlying white matter,[48-50] subcortical or in a hemisphere 
excluding the basal ganglia or thalamus,[51-53] or in any lobe(s) of the brain[54-61]). 
Of 28 studies which defined ‘non-lobar’ ICH, 20 defined ‘non-lobar’ as involving the 
basal ganglia or infratentorial regions,[18,25,27,32,33,36,38,45-47,50-54,56-60] seven 
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included deep periventricular white matter,[41-44,48,49,61] and one included 
‘subcortical’ structures.[55] 
Therefore, we sought to define and categorise lobar and non-lobar ICH in a 
prospective, population-based cohort study in order to determine ICH incidence and 
its outcome by location, and investigate whether any differences are explained by 
baseline characteristics. 
Methods 
Community-based inception cohort study of ICH 
The Lothian Audit of the Treatment of Cerebral Hemorrhage (LATCH) ascertained 
all residents in the Lothian Health board region of Scotland (mid-2010 population 
aged ≥16 years was 695,335) who were aged ≥16 years at the time they were 
diagnosed with first-ever or recurrent ICH confirmed by brain imaging or pathology 
between 1st June 2010 and 31st May 2011 inclusive. We excluded adults with 
exclusively extra-axial intracranial haemorrhage or ICH definitely attributable to 
trauma or hemorrhagic transformation of an ischaemic stroke. 
We identified incident ICH cases using multiple overlapping sources of case 
ascertainment.  Prospective ‘hot pursuit’ sources included a collaborative Lothian-
wide network of physicians, neurologists, neurosurgeons, radiologists, pathologists, 
stroke specialist nurses and stroke audit personnel, daily multidisciplinary 
neuroradiology meetings and a daily review of all CT head scans.  We retrospectively 
reviewed the electronic patient records system in secondary care, records of sudden 
deaths held by the Office of the Procurator Fiscal, the Scottish Stroke Care Audit 
[www.strokeaudit.scot.nhs.uk], and ICD-10-coded central records of hospital 
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discharges held by the Information Services Division [www.isdscotland.org]) for 
cases missed by hot pursuit. 
Definition of lobar and non-lobar ICH 
We defined ICH as a symptomatic event (new headache, altered level of 
consciousness or neurological symptoms), with or without new neurological signs, 
referable to a focal collection of blood within the brain parenchyma (seen on brain 
imaging or at autopsy), with signal characteristics on brain imaging or organisation of 
the haematoma at autopsy consistent with the time of symptom onset, which was not 
attributable to prior trauma or haemorrhagic transformation of an ischaemic stroke or 
an alternative explanation. 
At least one experienced consultant neuroradiologist (with a special interest in stroke 
and greater than 10 years neuroradiological practice) reviewed diagnostic brain 
imaging and classified ICH location as ‘non-lobar’ if an adult had a single 
infratentorial ICH (located in the brainstem or cerebellum), a single supratentorial 
deep ICH (located in the basal ganglia, internal or external capsule or thalamus 
without extension to a lobar area), or multiple ICHs in solely non-lobar locations 
(either supratentorial deep or infratentorial).  All other ICHs were ‘lobar’. 
Clinical information 
We collected clinical variables by interviewing patients or their families at the time of 
presentation and reviewing primary care and hospital records.  We used two different 
definitions of hypertension.  Firstly, we classified an adult as having a past history of 
hypertension if either a history of hypertension had been documented in their medical 
records or if they were taking antihypertensive medications at the time of their ICH.  
Secondly, we compared the proportion of participants taking antihypertensive 
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medications between the two groups as a surrogate marker of how well hypertension 
was controlled in the two groups.  We classified an adult as having a past history of 
dementia either if dementia had been diagnosed prior to the ICH or if a relative or 
close friend completed the Informant Questionnaire on Cognitive Decline in the 
Elderly (IQCODE) and the score was ≥64.[62] 
We used multiple sources of follow-up including those used for case ascertainment, 
death certificates and questionnaires sent annually to each adult’s GP to determine 
vital status at one year, dependence according to the modified Rankin scale,[63] and 
the occurrence of recurrent ICH in the first year following their ICH. 
Regulatory approval 
LATCH was approved by the NHS Lothian Caldicott Guardian. Patients in NHS 
Lothian were informed about the use of their data for audit, and information leaflets 
about LATCH were distributed to inform patients and their carers about their right to 
opt out. Analyses of an anonymised dataset, extracted from the audit database held on 
NHS and University servers, did not require research ethics committee approval. 
Patients with ICH ascertained by LATCH, had the opportunity to consent to 
participate in the Lothian IntraCerebral Haemorrhage, Pathology, Imaging and 
Neurological Outcome (LINCHPIN) study, a prospective community-based research 
study examining the causes of ICH using brain MRI and research autopsy in case of 
death.  The Scotland A Research Ethics Committee approved the study 
(10/MRE00/23). 
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Statistical analysis 
We compared demographic, clinical and radiological characteristics in adults with 
lobar and non-lobar ICH using parametric statistics when characteristics conformed to 
a normal distribution and non-parametric statistics when they did not.  For adults who 
underwent brain imaging (and were not diagnosed at autopsy) we calculated 
haematoma volume using the first CT brain scan after the adult’s presentation with 
ICH using Quantomo computerised planimetry software (Cybertrial Inc, Calgary, 
Canada), which has been shown to have greater reliability for quantifying ICH 
volume in comparison to the ABC/2 method.[64,65] 
We externally validated the ICH Score[8] for survival at one year.  Because of small 
sample size bias potentially leading to over-estimation of odds ratios,[66] we repeated 
the multivariable analysis using a penalised maximum likelihood logistic regression 
[67](firthlogit command in Stata).  Since the two models were very similar and 
the penalised regression model does not provide a goodness-of-fit statistic, we have 
reported the results of the original multivariable analysis.  We assessed the 
performance of the ICH Score by calculating the area under a receiver operator 
characteristic curve (AUROC) using the values of the ICH score obtained for each 
participant. 
We used a multivariable logistic regression model to assess whether lobar ICH 
location (with infratentorial as the referent category), age, Glasgow Coma Scale 
(GCS) score on admission, intraventricular extension, ICH volume and prior 
anticoagulant use were associated with survival at one year.  We pre-specified these 
variables on the basis of their clinical relevance, known or hypothesised influences on 
outcome,[8,68] and the number of outcome events per variable since five to nine 
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outcome events per variable is valid, especially if variables are selected a priori and 
the associations found are plausible in the context of current knowledge.[69] We 
checked the calibration of the model using a likelihood ratio and Hosmer and 
Lemeshow’s goodness of fit test which divides subjects into deciles based on 
predicted probabilities of case fatality and calculates a χ2 statistic based upon 
observed and expected frequencies of deaths in each decile (p >0.05 indicates that 
there is no significant difference between the observed and model-predicted values, 
implying that the model fits the data adequately).[70]  Survival analyses of the time to 
an event started on the date of ICH symptom onset/detection and ended either on the 
date of the first event or on the date of censoring if no event occurred during follow-
up.  We censored follow-up on the date of death or one year after their ICH depending 
on which occurred first.  For symptomatic outcome events, we calculated the total 
person-years of follow up using the sum of follow-up times irrespective of whether an 
event took place or whether the person was censored.  For survival analyses, we 
quantified the completeness of follow-up by calculating the sum of follow-up times 
(days) divided by the sum of potential follow-up times which could have been 
obtained before death or the end of the one year follow-up period.[71] We used 
Kaplan-Meier survival curves and life tables with log rank tests and hazard ratios to 
analyse follow up data for outcome events during one-year follow-up.  We conducted 
all analyses in Stata version 11.1. 
Results 
Of 166 adults with incident ICHs (Figure 1), the diagnosis of ICH was confirmed by 
brain CT in 162 (98%) cases and the rest were diagnosed at autopsy. 162 (98%) were 
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ascertained by one or more hot pursuit mechanisms. 30 (18%) also underwent brain 
MRI.  Brain CT was done within two days of symptom onset in 144 (87%) cases. 
There were 25 secondary ICHs and 141 primary ICHs, of which 128 (91%) were first-
ever-in-a-lifetime ICHs (Figure 1).  The analyses of baseline characteristics and 
outcome after ICH are restricted to 128 first-ever ICHs. 
The crude incidence of first-ever and recurrent spontaneous (primary and secondary) 
ICH in adults in the Lothian health board region of Scotland during 1st June 2010-
31st May 2011 was 0.24 per 1000 per year (95% confidence interval [CI] 0.21 to 
0.27).  The incidence of first-ever spontaneous primary ICH was 0.18 per 1000 per 
year (95% CI 0.16 to 0.22) and the age-standardised incidence directly adjusted to the 
mid-2010 population estimates for the UK was 0.21 per 1000 per year (95% CI 0.20 
to 0.21).. The incidence of both spontaneous first-ever lobar and non-lobar primary 
ICH increased across all age groups (Table I, online supplement).  The overall 
incidence of lobar ICH was similar to non-lobar ICH (9.8 [95% confidence interval 
(CI) 7.7-12.4] versus 8.6 [95%CI 6.7-11.1] per 100,000 adults per year).  The 
incidence of primary first-ever ICH associated with anti-thrombotic medication use 
was 0.09 per 1000 per year (95% CI 0.07 to 0.12). 
Locations of haemorrhages in adults with first-ever 
spontaneous primary ICH 
60 (47%) adults had non-lobar, spontaneous, primary, first-ever ICH (single non-lobar 
[n=59] and multiple non-lobar [n=1]), and the location of the remaining 68 (53%) was 
lobar (single lobar [n=61], single lobar extending to non-lobar regions [n=4], multiple 
lobar and non-lobar [n=2], and multiple lobar [n=1]). 
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Baseline characteristics of adults with first-ever lobar and 
non-lobar ICH 
We compared the characteristics of adults with a spontaneous primary first-ever ICH 
(hereafter simply referred to as ‘ICH’) involving any lobar region to those with non-
lobar ICH (Table 1). The proportion of adults with a past history of hypertension did 
not differ between those with lobar and non-lobar ICH (Table 1) and this was 
unchanged when the definition of hypertension was restricted to those taking 
antihypertensive medications at the time of the ICH (lobar 33 (49%) vs. non-lobar 29 
(48%), χ2 =0.01, p=0.92). A history of dementia was more common in adults with 
lobar ICH.  The IQCODE was available for 47 (37%) adults, who were more likely to 
have reached further or higher education and less likely to have had an ischaemic 
stroke, but did not significantly differ in age or ICH location from adults without an 
IQCODE (Table II, Supplementary file). Admission GCS scores were significantly 
lower and ICH volumes were larger in the lobar ICH group.  Extension of the ICH 
into the subdural and subarachnoid compartments was more common in the lobar ICH 
group. 
Outcome after first-ever primary ICH 
Completeness of one-year outcome data was 100% for vital status and 97% for 
dependence. By one year, 72 adults (56%, 95% CI 48-65%) had died and the 
proportions did not differ between lobar and non-lobar ICH (lobar 39/68 [57%]; non-
lobar 33/60 [55%]), χ2 =0.07, p=0.79). By one year, 107 (86%) adults were dead or 
dependent (modified Rankin scale score ≥ 3), but this proportion did not vary by ICH 
location (lobar 58/68 [88%] vs non-lobar 49/60 [84%]; χ2 =0.30, p=0.58).  Three 
adults underwent surgical intervention; two adults with lobar ICH underwent insertion 
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of a ventricular drain and one adult with a deep ICH underwent craniotomy and ICH 
evacuation. 
Predictors of death in the first year 
In a multivariable regression analysis of 122 adults with first-ever primary ICH using 
explanatory variables defined according to the ICH score, age (≥80 years), decreasing 
GCS on admission, ICH volume (≥30ml) and infratentorial ICH were the components 
of the ICH Score associated with death at one year (Table 2).  In a sensitivity analysis 
using a penalised maximum likelihood logistic regression model, the results were 
unchanged (age ≥80 years OR 2.57, 95% CI 1.08-6.16; GCS 5-12 OR 2.56, 95% CI 
1.00-6.61; GCS 3-4 OR 5.62, 95% CI 0.82-38.74 (using GCS 13-15 as the referent 
category); ICH volume >30ml OR 3.32, 95% CI 1.21-9.14; infratentorial ICH OR 
5.70, 95% CI 1.18-27.53 and intraventricular extension OR 1.89, 95% CI 0.80-4.54).  
The AUROC was 0.82 (95% CI 0.74 to 0.89) indicating that the ICH Score 
discriminated well between those who survived and those who did not in the first year 
after first-ever ICH.   
In a multivariable logistic regression analysis of 122 adults with first-ever primary 
ICH (Table 3), in comparison to infratentorial ICH, lobar ICH was associated with a 
20-fold lower odds of death at one year (adjusted odds ratio [OR] 0.05, 95% CI 0.01 
to 0.38) and deep ICH was associated with a six-fold lower odds of death, although 
this difference was not statistically significant (adjusted OR 0.16, 95% CI 0.02 to 
1.26; p=0.08).  Older age, lower GCS scores on admission and larger ICH volumes on 
brain imaging were also independent predictors of death.  The model was well 
calibrated (Likelihood ratio test p<0.001; Hosmer and Lemeshow’s goodness of fit 
test χ2 =3.71, p=0.88).  In a sensitivity analysis comparing lobar vs. non-lobar ICH, 
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one-year case fatality was lower after lobar ICH than after non-lobar ICH (adjusted 
OR for death at one year: lobar vs. non-lobar ICH 0.21, 95% CI 0.07 to 0.63; 
p=0.006, after adjustment for known predictors of outcome). In view of these 
findings, we reclassified location in the ICH Score as lobar, deep or infratentorial 
(with scores of 0,1 and 2 respectively) but this did not improve the discrimination of 
the ICH Score at one year (AUROC 0.82, 95% CI 0.75-0.89). 
Recurrent ICH after primary ICH 
During 63 person-years of follow-up (97% completeness at one year) there were four 
recurrent ICHs, all of which were in lobar locations following prior primary lobar 
ICH (annual risk of recurrent ICH after lobar ICH 11.8%, 95% CI 4.6% to 28.5% vs. 
annual risk after non-lobar ICH 0%; p=0.04; Figure II, online supplement).  
Discussion 
Adults with lobar ICH were more likely to have preceding dementia, a lower 
admission GCS score and larger ICHs with subarachnoid extension and subdural 
extension in comparison to those with non-lobar ICH. However, adults with lobar 
ICH were significantly more likely to survive one year compared to adults with non-
lobar ICH after adjustment for other known predictors of outcome.  The ICH Score 
discriminated well between those who survived and those who died in the first year 
after ICH. The risk of recurrent ICH was higher after lobar ICH. 
We used a prospective, population-based design with multiple overlapping sources of 
case ascertainment and follow-up and a sample size sufficient to permit multivariable 
analyses.  An experienced neuroradiologist with a special interest in stroke classified 
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all ICH locations in a multi-disciplinary meeting in which usually more than one 
neuroradiologist was present.  There has been good inter-observer agreement in the 
assessment of supratentorial ICH location even for larger haematomas.[72] This is the 
first study to externally validate the ICH Score to determine one year survival in a 
population-based cohort. 
The first year of this ongoing study has a small sample size, short follow up period 
and small number of outcome events.  The multiple comparisons of baseline 
characteristics may have increased the likelihood of a statistically significant result 
occurring by chance. We obtained a history of dementia in all participants by 
reviewing their hospital and primary care records (although relatives completed the 
IQCODE questionnaire as well in only 37%). Adults without an IQCODE were more 
likely to have not reached further or higher education and have a past history of 
ischaemic stroke raising the possibility of underascertainment of premorbid dementia, 
but the proportion of participants with dementia was very similar to another cohort of 
participants with ICH [73]and since ICH location did not differ between participants 
for whom an IQCODE was obtained and others, any resulting misclassification of 
exposure is likely to have been non-differential.  We did not adjust for premorbid 
conditions which might affect outcome,[74] but since most characteristics in both 
lobar and non-lobar ICH groups were similar it is unlikely that this affected the 
findings. Similarly, we did not adjust for the presence of subarachnoid extension,[75] 
as this is associated with a larger ICH volume which is likely to be the primary 
determinant of poor outcome.[76]  We only categorised the presence or absence of 
intraventricular haemorrhage rather than determining the extent of it[77] and did not 
adjust for participants’ do-not-resuscitation status which may influence outcome.[8] 
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We assessed intraventricular haemorrhage on the first (diagnostic) CT and therefore 
may have missed patients who had delayed intraventricular haemorrhage.[78]  
We found the incidence of ICH to be comparable to the findings of a recent meta-
analysis, in which the incidence had not changed for several decades.[1] The 
incidence of antithrombotic drug-associated ICH was comparable to that of another 
contemporary population-based cohort[7] and its frequency did not differ according to 
ICH location (Table 1). 
Age and pre-morbid hypertension did not differ according to ICH location in our 
cohort, which is similar to the findings of other population-based studies.[79] 
Two[61][[73] of five hospital-based studies[32,45,51,61,73] have also found pre-
morbid dementia to be more common in those with lobar ICH, which may reflect the 
higher prevalence of CAA underlying lobar ICH. 
Lobar ICH has been associated with a better outcome in a population-based study,[11] 
but not in others,[14,17,18] which may be due to confounding. We found that lobar 
ICH location influenced survival and risk of recurrent ICH, independent of other 
known prognostic factors.  Lobar ICHs may be associated with a better outcome in 
comparison to ICH in other locations, despite differences in ICH volume, because 
lobar anatomy and cortical atrophy,given the higher prevalence of pre-ICH 
dementia[73], may protect against mass effect resulting from ICH. 
The risk of recurrent ICH in the lobar ICH group is similar to previous studies,[21] 
which may be due to the prevalence of CAA in lobar regions,or perhaps due to the 
severity of other vasculopathies in survivors of deep ICH. 
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Since patients with lobar ICH are more likely to survive, but are also at higher risk of 
ICH recurrence (Figure II, online supplement),[80-82], secondary prevention with 
antihypertensive drugs[83] may be particularly relevant to this group of patients.  
Larger studies could examine the influence of biomarkers of CAA[84,85] and other 
causes of ICH[86] on outcome and recurrent ICH. Since survivors of ICH have higher 
mortality in comparison to the general population[87] and given the apparently higher 
risk of ICH recurrence after lobar ICH (Figure II, online supplement),[21] treatments 
directed at the specific small vessel diseases underlying ICH, such as CAA, may 
improve outcome (Study Evaluating the Safety, Tolerability and Efficacy of PF-
04360365 in Adults With Probable Cerebral Amyloid Angiopathy”, NCT01821118). 
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Figures 
Figure 1 
Flowchart of adults with spontaneous ICH included in the study 
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Table 1 
 Lobar ICH (n=68) Non-lobar ICH (n=60) p value 
Sex (male), (%) 26 (38) 29 (48) 0.25 
Age (years); median (IQR) 79 (15) 76 (19) 0.84 
History of hypertension* 
Yes (n, %) 
 
40 (59) 
 
41 (68) 
 
 
0.21 
History of diabetes* 
Yes (n, %) 
 
5 (7) 
 
8 (13) 
 
0.25 
History of dementia 
Yes (n, %) 
 
14 (21) 
 
 
3 (5) 
 
0.01 
 
History of smoking* 
Never (n, %) 
Ex-smoker (n, %) 
Current (n, %) 
 
30 (44) 
20 (29) 
17 (25) 
 
26 (43) 
24 (40) 
10 (17) 
 
 
 
0.40 
Alcohol consumption$ 2 (0-14) 4 (0-14) 0.70 
Premorbid medication 
Antiplatelet use* (n, %) 
Anticoagulant use (n, %) 
 
28 (41) 
8 (12) 
 
19 (32) 
10 (17) 
 
0.24 
0.43 
Admission GCS score** 
median (IQR) 
 
13 (9-14) 
 
14 (10-15) 
 
0.03 
Admission systolic blood 
pressure (mmHg)^ 
mean (SD) 
 
117 (28) 
 
123 (23) 
 
0.22 
ICH volume (ml)^^ 
median, (IQR) 
 
38 (17-74) 
 
11 (4-25) 
 
<0.001 
Intraventricular extension^^ 
Yes (n, %) 
 
33 (51) 
 
31 (53) 
 
0.85 
Subarachnoid extension^^ 
Yes (n, %) 
 
37 (57) 
 
3 (5) 
 
<0.001 
Subdural extension^^ 
Yes (n, %) 
 
10 (15) 
 
2 (3) 
 
0.02 
*Data missing for one adult 
$average number of units per week (median; IQR); data missing in 9 cases 
** data missing in five cases (three of whom died in the community) 
^ data missing in 12 cases (three of whom died in the community) 
^^data missing in four cases for whom the diagnosis was confirmed at autopsy 
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Table 2 
Variable Adjusted OR, 95% CI p 
Age (≥80 years) 2.75 (1.11-6.80) 0.03 
Glasgow coma scale 
13-15 
5-12 
3-4 
 
1.00 
2.71 (1.01-7.26) 
8.18 (0.86-78.15) 
 
 
0.048 
0.07 
ICH volume (≥ 30ml) 3.57 (1.25-10.21) 0.02 
Infratentorial ICH 7.15 (1.29-39.75) 0.03 
Presence of intraventricular extension 0.51 (0.20-1.25) 0.14 
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Table 3 
Variable Adjusted OR, 95% CI p 
Increasing age (per year) 1.07 (1.03-1.11) 0.001 
Increasing Glasgow coma scale score (per 
point) 
0.81 (0.67-0.97) 0.02 
Increasing ICH volume (per ml) 1.05 (1.02-1.08) 0.001 
ICH location 
Infratentorial 
Deep 
Lobar 
 
1.00 
0.16 (0.02-1.26) 
0.05 (0.01-0.38) 
 
 
0.08 
0.01 
Presence of intraventricular extension 0.61 (0.22-1.75) 0.36 
Anticoagulant use at presentation with ICH 1.56 (0.30-7.97) 0.60 
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